Cargando…
Safety and efficacy of the CELT ACD femoral arteriotomy closure device in the office-based laboratory
OBJECTIVE: Manual compression remains the gold standard for achieving hemostasis for percutaneous common femoral artery access. However, it requires prolonged bedrest and 20 to 30 minutes or more of compression for hemostasis. Current arterial closure devices have emerged in recent years, but patien...
Autores principales: | Ghamraoui, Ahmed K., Forman, Jake, Ricotta, John, Ricotta, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318519/ https://www.ncbi.nlm.nih.gov/pubmed/37408945 http://dx.doi.org/10.1016/j.jvscit.2023.101139 |
Ejemplares similares
-
Maldeployment of Celt ACD vascular closure device
por: Hart, Benjamin, et al.
Publicado: (2021) -
Endovascular Management of Superficial Femoral Artery Occlusion Secondary to Embolization of Celt ACD(®) Vascular Closure Device
por: Fataftah, Jehad, et al.
Publicado: (2020) -
Successful surgical retrieval of Celt ACD® vascular closure device embolised in the tibioperoneal trunk
por: Aljarrah, Qusai, et al.
Publicado: (2018) -
Vascular Closure Devices after Femoral Arteriotomy: Insight in High‐Risk Patients
por: Thakker, Ravi, et al.
Publicado: (2022) -
A Retrospective Review on Feasibility and Safety of a New Pneumatic Compression Device for Femoral Arteriotomy Hemostasis
por: Kang, Minho, et al.
Publicado: (2012)